Literature DB >> 9212359

C-reactive protein: structural biology, gene expression, and host defense function.

A J Szalai1, A Agrawal, T J Greenhough, J E Volanakis.   

Abstract

Over the past few years substantial insight was gained into the biology and biochemistry of human C-reactive protein (CRP). X-ray crystallography in conjunction with mutational analyses, generated the three-dimensional structure of the protein and indicated the topology and structure of ligand-binding sites. Using human CRP transgenic mice infected with Streptococcus pneumoniae, we obtained data that clearly established CRP as an important host defense molecule. Studies using the same mice revealed a previously unknown testosterone-dependence of constitutive expression of human CRP. In this article we provide a brief overview of these recent findings.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9212359     DOI: 10.1007/bf02786357

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  29 in total

1.  The covalent and three-dimensional structure of concanavalin A. IV. Atomic coordinates, hydrogen bonding, and quaternary structure.

Authors:  G N Reeke; J W Becker; G M Edelman
Journal:  J Biol Chem       Date:  1975-02-25       Impact factor: 5.157

2.  Isolation of a peptido-polysaccharide from the dermatophyte Epidermophyton floccosum and a study of its reaction with human C-reactive protein and a mouse anti-phosphorylcholine myeloma serum.

Authors:  B A Baldo; T C Fletcher; J Pepys
Journal:  Immunology       Date:  1977-06       Impact factor: 7.397

3.  Role of complement in C-reactive-protein-mediated protection of mice from Streptococcus pneumoniae.

Authors:  A J Szalai; D E Briles; J E Volanakis
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

4.  Demonstration of calcium-induced conformational change(s) in C-reactive protein by using monoclonal antibodies.

Authors:  J M Kilpatrick; J F Kearney; J E Volanakis
Journal:  Mol Immunol       Date:  1982-09       Impact factor: 4.407

5.  Localization of the phosphocholine-binding sites on C-reactive protein by immunoelectron microscopy.

Authors:  K H Roux; J M Kilpatrick; J E Volanakis; J F Kearney
Journal:  J Immunol       Date:  1983-11       Impact factor: 5.422

6.  Regulation of the human C-reactive protein gene in transgenic mice.

Authors:  C Murphy; J Beckers; U Rüther
Journal:  J Biol Chem       Date:  1995-01-13       Impact factor: 5.157

7.  The critical role of complement in experimental pneumococcal sepsis.

Authors:  S W Hosea; E J Brown; M M Frank
Journal:  J Infect Dis       Date:  1980-12       Impact factor: 5.226

8.  Structure of pentameric human serum amyloid P component.

Authors:  J Emsley; H E White; B P O'Hara; G Oliva; N Srinivasan; I J Tickle; T L Blundell; M B Pepys; S P Wood
Journal:  Nature       Date:  1994-01-27       Impact factor: 49.962

9.  C-reactive protein binds to Fc gamma RI in transfected COS cells.

Authors:  L L Marnell; C Mold; M A Volzer; R W Burlingame; T W Du Clos
Journal:  J Immunol       Date:  1995-08-15       Impact factor: 5.422

10.  THE OCCURRENCE DURING ACUTE INFECTIONS OF A PROTEIN NOT NORMALLY PRESENT IN THE BLOOD : I. DISTRIBUTION OF THE REACTIVE PROTEIN IN PATIENTS' SERA AND THE EFFECT OF CALCIUM ON THE FLOCCULATION REACTION WITH C POLYSACCHARIDE OF PNEUMOCOCCUS.

Authors:  T J Abernethy; O T Avery
Journal:  J Exp Med       Date:  1941-01-31       Impact factor: 14.307

View more
  25 in total

Review 1.  Diversity and duplicity: human FCgamma receptors in host defense and autoimmunity.

Authors:  Robert P Kimberly; Jianming Wu; Andrew W Gibson; Kaihong Su; Hongwe Qin; Xiaoli Li; Jeffrey C Edberg
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

2.  Mannose-binding lectin does not act as an acute-phase reactant in adults with community-acquired pneumococcal pneumonia.

Authors:  M Perez-Castellano; M Peñaranda; A Payeras; J Milà; M Riera; J Vidal; F Pujalte; A Pareja; C Villalonga; N Matamoros
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

Review 3.  Varied biologic functions of C-reactive protein: lessons learned from transgenic mice.

Authors:  Alexander J Szalai; Mark A McCrory
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

4.  Carbohydrate ligands of human C-reactive protein: binding of neoglycoproteins containing galactose-6-phosphate and galactose-terminated disaccharide.

Authors:  Reiko T Lee; Yuan C Lee
Journal:  Glycoconj J       Date:  2006-07       Impact factor: 2.916

5.  Interleukin-6 (IL-6) and C-reactive protein (CRP) concentration prior to total nephrectomy are prognostic factors in localized renal cell carcinoma (RCC).

Authors:  Michał Hrab; Karolina Olek-Hrab; Andrzej Antczak; Zbigniew Kwias; Tomasz Milecki
Journal:  Rep Pract Oncol Radiother       Date:  2013-07-26

6.  Macrophage conditioned medium induces the expression of C-reactive protein in human aortic endothelial cells: potential for paracrine/autocrine effects.

Authors:  Senthil Kumar Venugopal; Sridevi Devaraj; Ishwarlal Jialal
Journal:  Am J Pathol       Date:  2005-04       Impact factor: 4.307

7.  Mannose binding lectin acute phase activity in patients with severe infection.

Authors:  M M Dean; R M Minchinton; S Heatley; D P Eisen
Journal:  J Clin Immunol       Date:  2005-07       Impact factor: 8.317

Review 8.  C-reactive protein, inflammation, and innate immunity.

Authors:  R F Mortensen
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

9.  Effects of C-reactive protein and pentosan polysulphate on human complement activation.

Authors:  Andis Klegeris; Edith A Singh; Patrick L McGeer
Journal:  Immunology       Date:  2002-07       Impact factor: 7.397

Review 10.  CRP identifies homeostatic immune oscillations in cancer patients: a potential treatment targeting tool?

Authors:  Brendon J Coventry; Martin L Ashdown; Michael A Quinn; Svetomir N Markovic; Steven L Yatomi-Clarke; Andrew P Robinson
Journal:  J Transl Med       Date:  2009-11-30       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.